Today, the Coalition to Reduce Spending was proud to join a bipartisan group of organizations urging Congressional leadership take action on the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
This legislation would encourage competition in the drug industry, lowering prescription prices for both consumers and the government.
We’re proud to add our name alongside over 35 diverse stakeholders and push for meaningful healthcare reform.
Read the full letter here.
On Friday, the U.S. officially surpassed $20 trillion in debt, according to the Treasury Department. This milestone marks an inevitable but deeply disappointing moment for fiscal conservatives of all kinds.
This historic moment in our nation’s history further signals the need for spending reforms and fiscal responsibility across the federal government.
There is no better time than now to demand to our elected officials that dealing with our runaway debt and spending should be at the forefront of all policy discussions.
If I told you Republican Senators Mike Lee (R-UT) and John McCain (R-AZ), came together with Democratic Senators Diane Feinstein (D-CA) and Patrick Leahy (D-VT)—among others—to sponsor a bill, would you believe it?
The Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (or CREATES Act) brings Senators from across the political spectrum together. The bill has the potential to bring down prices for government and consumers by encouraging competition in the drug market.
Under FDA regulations, drug companies are legally required to provide samples to FDA-approved generic companies when requested once a drug patent expires so that generics can prove their safety. FDA regulations also require that manufacturers participate in Risk Evaluation and Mitigation Strategies—or REMS—when dealing with dangerous and possibly fatal drugs, but brand-name manufacturers often refuse to share samples or let competitors participate in shared safety protocols.
With CREATES, generic manufacturers have a path to relief if companies refuse to sell samples of the drugs or participate in REMS.
Now, we’re hearing that the bill may be used as a pay-for to reauthorize the Children’s Health Insurance Program (CHIP) at the end of the month. While full details and potential savings are not yet known, this is an encouraging opportunity to see much-needed reforms that both sides can support, at a time when Congress seems to butt heads on nearly every other issue.
Today, the Coalition to Reduce Spending was proud to join alongside ten fiscally conservative organizations to urge Congressional leadership not to raise the debt limit “without significant reforms that put our nation on a path to fiscal balance.”
Year after year, Congress kicks the can down the road without any real steps in the direction of reform or restraint. Now under united Republican government and many members of Congress who got elected promising to cut spending, there is no excuse not to seek reforms.
We’re proud to add our name to efforts urging just that.
Read the full letter here.
Today, the Coalition to Reduce Spending was proud to join a diverse group of organizations urging Congress to take action on advancing longstanding balanced budget amendments proposals.
Our nation is facing a fiscal crisis. With $20 trillion in gross federal debt and $200 trillion or more in unfunded liabilities, experts recently agreed at House and Senate Judiciary Committee hearings that our nation risks a sovereign debt crisis.
Excessive federal borrowing risks more than economic or fiscal calamity – it is the civil rights issue of this century. By sending our children and future generations the bill for our policy choices, we deny them the right of self‐governance; tax them without representation; and deprive them of policy choices as interest payments consume more and more revenues.
As an economic, fiscal and civil rights issue, it is essential that the federal budget return to balance as soon as possible.
Read the full letter here